Mangoceuticals, Inc. (MGRX) has issued an update.
Mangoceuticals, Inc. has engaged a consultant with 192,308 shares of restricted stock and additional monetary compensation for services to be rendered until May 2025. Furthermore, the company has rewarded certain officers, an employee, and directors with a total of 1,250,000 shares of common stock as bonuses and for services in 2024, with the CEO receiving 800,000 of these shares. These transactions were made under exemptions from the usual securities registration requirements, emphasizing that the shares are subject to transfer restrictions and are only for accredited investors.
For detailed information about MGRX stock, go to TipRanks’ Stock Analysis page.
